| Date Filed | Type | Description |
| 01/23/2023 |
4
| Payne Fletcher (SR VP & Chief Fin. Officer) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Granted 100,000 shares
@ $0
Granted 200,000 options to buy
@ $0.66, valued at
$132k
|
|
| 09/21/2022 |
4
| Payne Fletcher (SR VP & Chief Fin. Officer) has filed a Form 4 on Aptose Biosciences Inc.|
Txns:
| Bought 10,000 shares
@ $0.6775, valued at
$6.8k
|
|
| 06/28/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 06/28/2022 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
| 09/25/2019 |
4
| Payne Fletcher (CFO) has filed a Form 4 on CATALYST BIOSCIENCES, INC. |
| 08/12/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/13/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 02/04/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 01/28/2019 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
| 08/01/2018 |
4
| Payne Fletcher (CFO) has filed a Form 4 on CATALYST BIOSCIENCES, INC.|
Txns:
| Granted 25,000 options to buy
@ $9.68, valued at
$242k
|
|
| 03/28/2018 |
4
| Payne Fletcher (CFO) has filed a Form 4 on CATALYST BIOSCIENCES, INC.|
Txns:
| Exercised 59 options to buy
@ $4.63, valued at
$273.2 |
|
| 01/16/2018 |
4
| Payne Fletcher (CFO) has filed a Form 4 on CATALYST BIOSCIENCES, INC.|
Txns:
| Granted 26,000 options to buy
@ $15.13, valued at
$393.4k
|
|
| 07/12/2017 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |